This bill establishes a comprehensive strategy to strengthen America's ability to prevent, prepare for, and respond to seasonal and pandemic influenza. The legislation sets national goals including delivering pandemic flu vaccine doses within 12 weeks of a new strain's emergence (within 3 years) and developing a universal flu vaccine (within 10 years). It authorizes substantial funding across multiple agencies, including $335 million annually through 2028 for the Biomedical Advanced Research and Development Authority, plus hundreds of millions more for vaccine programs, stockpiles, and preparedness efforts at the CDC and other health agencies. The bill affects vaccine manufacturers, healthcare providers, pharmacies, public health agencies, and the general public by requiring improved vaccine distribution networks, expanded at-home testing capabilities, better treatments, and targeted outreach to combat vaccine hesitancy among vulnerable populations including minorities, seniors, and people with chronic illnesses. Key timelines require plans and reports within 6 months to 1 year on various initiatives, with ongoing implementation and annual reporting through 2030 for vaccine modernization efforts.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.